{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:04:41Z","timestamp":1794578681216,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1038\/s41440-022-00908-1","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T05:02:51Z","timestamp":1650258171000},"page":"936-943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Blood pressure management for secondary stroke prevention"],"prefix":"10.1038","volume":"45","author":[{"given":"Kazuo","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"908_CR1","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","volume":"45","author":"JF Meschia","year":"2014","unstructured":"Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45:3754\u2013832.","journal-title":"Stroke"},{"key":"908_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957\u201367.","journal-title":"Lancet"},{"key":"908_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/HYPERTENSIONAHA.116.08485","volume":"69","author":"AH Katsanos","year":"2017","unstructured":"Katsanos AH, Filippatou A, Manios E, Deftereos S, Parissis J, Frogoudaki A, et al. Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials. Hypertension. 2017;69:171\u20139.","journal-title":"Hypertension"},{"key":"908_CR4","unstructured":"Toyoda K, Nakayama M. Japan Stroke Data Bank. Japan Stroke Data Bank 2021 edited by Editorial Board of Japan Stroke Data bank, Tokyo: National Cerebral and Cardiovascular Center, Nakayama Shoten., Ltd; 2021, p. 20\u201327."},{"key":"908_CR5","doi-asserted-by":"publisher","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","volume":"141","author":"MK Chung","year":"2020","unstructured":"Chung MK, Eckhardt LL, Chen LY, Ahmed HM, Gopinathannair R, Joglar JA, et al. Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association. Circulation. 2020;141:e750\u2013e772.","journal-title":"Circulation"},{"key":"908_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/brain\/124.2.249","volume":"124","author":"J van Gijn","year":"2001","unstructured":"van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124:249\u201378.","journal-title":"Brain"},{"key":"908_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.5551\/jat.GL2017","volume":"25","author":"M Kinoshita","year":"2018","unstructured":"Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, et al. Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb. 2018;25:846\u2013984.","journal-title":"J Atheroscler Thromb"},{"key":"908_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","volume":"358","author":"PROGRESS Collaborative Group.","year":"2001","unstructured":"PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033\u201341.","journal-title":"Lancet"},{"key":"908_CR9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","volume":"359","author":"S Yusuf","year":"2008","unstructured":"Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N. Engl J Med. 2008;359:1225\u201337.","journal-title":"N. Engl J Med"},{"key":"908_CR10","doi-asserted-by":"publisher","first-page":"CD007858","DOI":"10.1002\/14651858","volume":"7","author":"TP Zonneveld","year":"2018","unstructured":"Zonneveld TP, Richard E, Vergouwen MD, Nederkoorn PJ, de Haan R, Roos YB, Kruyt ND. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2018;7:CD007858 https:\/\/doi.org\/10.1002\/14651858.","journal-title":"Cochrane Database Syst Rev"},{"key":"908_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/01.STR.0000106480.76217.6F","volume":"35","author":"N Chapman","year":"2004","unstructured":"Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S, et al. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke. 2004;35:116\u201321.","journal-title":"Stroke"},{"key":"908_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","volume":"382","author":"OR Benavente","year":"2013","unstructured":"SPS3 Study Group, Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, Pearce LA, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382:507\u201315.","journal-title":"Lancet"},{"key":"908_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","volume":"76","author":"K Kitagawa","year":"2019","unstructured":"Kitagawa K, Yamamoto Y, Arima H, Maeda T, Sunami N, Kanzawa T, et al. Effect of Standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol. 2019;76:1309\u201318.","journal-title":"JAMA Neurol"},{"key":"908_CR14","doi-asserted-by":"crossref","unstructured":"Kitagawa K, Arima H, Yamamoto Y, Ueda S, Rakugi H, Kohro T, et al. Intensive or standard blood pressure control in patients with a history of ischemic stroke: respect post-hoc analysis. Hypertens Res. 2022;45:591\u2013601.","DOI":"10.1038\/s41440-022-00862-y"},{"key":"908_CR15","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl J Med. 2015;373:2103\u201316.","journal-title":"N. Engl J Med"},{"key":"908_CR16","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1161\/01.STR.24.12.1844","volume":"24","author":"K Irie","year":"1993","unstructured":"Irie K, Yamaguchi T, Minematsu K, Omae T. The J-curve phenomenon in stroke recurrence. Stroke. 1993;24:1844\u20139.","journal-title":"Stroke"},{"key":"908_CR17","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","volume":"24","author":"H Arima","year":"2006","unstructured":"Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24:1201\u20138.","journal-title":"J Hypertens"},{"key":"908_CR18","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1001\/jama.2011.1650","volume":"306","author":"B Ovbiagele","year":"2011","unstructured":"Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, et al. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA. 2011;306:2137\u201344.","journal-title":"JAMA"},{"key":"908_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000003489","volume":"88","author":"NA Hilkens","year":"2017","unstructured":"Hilkens NA, Greving JP, Algra A, Klijn CJ. Blood pressure levels and the risk of intracerebral hemorrhage after ischemic stroke. Neurology. 2017;88:177\u201381.","journal-title":"Neurology"},{"key":"908_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.12.003","volume":"22","author":"B Ovbiagele","year":"2013","unstructured":"Ovbiagele B. Low-normal systolic blood pressure and secondary stroke risk. J Stroke Cerebrovasc Dis. 2013;22:633\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"908_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.115.06480","volume":"67","author":"MC Odden","year":"2016","unstructured":"Odden MC, McClure LA, Sawaya BP, White CL, Peralta CA, Field TS, et al. Achieved Blood pressure and outcomes in the secondary prevention of small subcortical strokes trial. Hypertension. 2016;67:63\u20139.","journal-title":"Hypertension"},{"key":"908_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/jama.2015.10082","volume":"314","author":"A Biffi","year":"2015","unstructured":"Biffi A, Anderson CD, Battey TW, Ayres AM, Greenberg SM, Viswanathan A, et al. Association between blood pressure control and risk of recurrent intracerebral hemorrhage. JAMA. 2015;314:904\u201312.","journal-title":"JAMA"},{"key":"908_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/ijs.12269","volume":"9","author":"CJ Estol","year":"2014","unstructured":"Estol CJ, Bath PMW, Gorelick PB, Cotton D, Martin RH. Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial. Int J Stroke. 2014;9:43\u20137.","journal-title":"Int J Stroke"},{"key":"908_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/2396987318797245","volume":"4","author":"T Hoshino","year":"2019","unstructured":"Hoshino T, Sissani L, Labreuche J, Bousser MG, Chamorro A, Fisher M, et al. Non-cardioembolic stroke\/transient ischaemic attack in Asians and non-Asians: a post-hoc analysis of the PERFORM study. Eur Stroke J. 2019;4:65\u201374.","journal-title":"Eur Stroke J"},{"key":"908_CR25","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1161\/STROKEAHA.107.504993","volume":"39","author":"K Toyoda","year":"2008","unstructured":"Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, et al. Bleeding with Antithrombotic Therapy (BAT) Study Group. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study. Stroke. 2008;39:1740\u20135.","journal-title":"Stroke"},{"key":"908_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1474-4422(19)30197-8","volume":"18","author":"D Wilson","year":"2019","unstructured":"Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, et al. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. Lancet Neurol. 2019;18:653\u201365.","journal-title":"Lancet Neurol"},{"key":"908_CR27","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1161\/01.STR.0000094424.38761.56","volume":"34","author":"PM Rothwell","year":"2003","unstructured":"Rothwell PM, Howard SC, Spence JD, Carotid Endarterectomy Trialists\u2019 Collaboration. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke. 2003;34:2583\u201390.","journal-title":"Stroke"},{"key":"908_CR28","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1161\/CIRCULATIONAHA.106.622464","volume":"115","author":"TN Turan","year":"2007","unstructured":"Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007;115:2969\u201375.","journal-title":"Circulation"},{"key":"908_CR29","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/jnnp-2013-305159","volume":"84","author":"H Yamauchi","year":"2013","unstructured":"Yamauchi H, Higashi T, Kagawa S, Kishibe Y, Takahashi M. Impaired perfusion modifies the relationship between blood pressure and stroke risk in major cerebral artery disease. J Neurol Neurosurg Psychiatry. 2013;84:1226\u201332.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00908-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00908-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00908-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T11:17:49Z","timestamp":1652440669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00908-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1038\/s41440-022-00908-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"KK reports grants and personal fees from Daiichi Sankyo, Bayer Inc., grants and personal fees from Nippon Boehringer Ingelheim, Kyowa Kirin, Sumitomo Dainippon Pharma, Astellas Pharma, and Sanofi, and personal fees from Takeda Pharmaceutical outside of the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}